{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:12:40Z","timestamp":1789560760085,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018917","name":"Hebei North University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Hebei Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["H20211405002"],"award-info":[{"award-number":["H20211405002"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jgeb.2026.100701","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T13:22:53Z","timestamp":1779974573000},"page":"100701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Relationship between expression of OGFR, P16, P21 and clinicopathological features of colorectal cancer patients"],"prefix":"10.1016","volume":"24","author":[{"given":"Zeyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benchang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqing","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jgeb.2026.100701_b0005","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100701_b0010","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12967-023-04260-x","article-title":"Predicting tumor repopulation through the gene panel derived from radiation resistant colorectal cancer cells","volume":"21","author":"Song","year":"2023","journal-title":"J Transl Med."},{"issue":"3","key":"10.1016\/j.jgeb.2026.100701_b0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41573-022-00615-z","article-title":"Rational combinations of targeted cancer therapies: background, advances and challenges","volume":"22","author":"Jin","year":"2023","journal-title":"Nat Rev Drug Discov."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100701_b0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1091\/mbc.e08-07-0681","article-title":"The OGF-OGFr axis utilizes the p16INK4a and p21WAF1\/CIP1 pathways to restrict normal cell proliferation","volume":"20","author":"Cheng","year":"2009","journal-title":"Mol Biol Cell."},{"key":"10.1016\/j.jgeb.2026.100701_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107713","article-title":"Research progress of opioid growth factor in immune-related diseases and cancer diseases","volume":"99","author":"Huang","year":"2021","journal-title":"Int Immunopharmacol."},{"issue":"2","key":"10.1016\/j.jgeb.2026.100701_b0030","first-page":"590","article-title":"Exogenous OGF enhances the anti-tumor activity of cisplatin on hepatocellular carcinoma","volume":"12","author":"Sikong","year":"2019","journal-title":"Int J Clin Exp Pathol."},{"key":"10.1016\/j.jgeb.2026.100701_b0035","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.2147\/IJGM.S434076","article-title":"Pan-cancer analysis and validation of opioid-related receptors reveals the immunotherapeutic value of toll-like receptor 4","volume":"16","author":"Wu","year":"2023","journal-title":"Int J Gen Med."},{"issue":"5","key":"10.1016\/j.jgeb.2026.100701_b0040","article-title":"Interaction of opioid growth factor (OGF) and opioid antagonist and their significance in cancer therapy","volume":"7","author":"Wang","year":"2019","journal-title":"Int Immunopharmacol."},{"issue":"2","key":"10.1016\/j.jgeb.2026.100701_b0045","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bja.2020.10.021","article-title":"Intraoperative opioids are associated with improved recurrence-free survival in triple-negative breast cancer","volume":"126","author":"Montagna","year":"2021","journal-title":"Br J Anaesth."},{"key":"10.1016\/j.jgeb.2026.100701_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.792290","article-title":"Opioid receptor-mediated and non-opioid receptor-mediated roles of opioids in tumour growth and metastasis","volume":"11","author":"Scroope","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.jgeb.2026.100701_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2023.102325","article-title":"Opioid growth factor receptor: anatomical distribution and receptor colocalization in neurons of the adult mouse brain","volume":"99","author":"Kareem","year":"2023","journal-title":"Neuropeptides."},{"key":"10.1016\/j.jgeb.2026.100701_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107733","article-title":"Methionine enkephalin activates autophagy and stimulates tumour cell immunogenicity in human cutaneous squamous cell carcinoma","volume":"96","author":"Bai","year":"2021","journal-title":"Int Immunopharmacol."},{"issue":"6","key":"10.1016\/j.jgeb.2026.100701_b0065","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1213\/ANE.0000000000001293","article-title":"Morphine suppresses lung cancer cell proliferation through the interaction with opioid growth factor receptor: an in vitro and human lung tissue study","volume":"123","author":"Kim","year":"2016","journal-title":"Anesth Analg."},{"issue":"2","key":"10.1016\/j.jgeb.2026.100701_b0070","first-page":"489","article-title":"Opioid growth factor receptor is unaltered with the progression of human pancreatic and colon cancers","volume":"29","author":"Zagon","year":"2006","journal-title":"Int J Oncol."},{"issue":"9","key":"10.1016\/j.jgeb.2026.100701_b0075","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/cid\/ciaa1317","article-title":"Primary HPV and molecular cervical cancer screening in US women living with human immunodeficiency virus","volume":"72","author":"Strickler","year":"2021","journal-title":"Clin Infect Dis."},{"issue":"3","key":"10.1016\/j.jgeb.2026.100701_b0080","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29524","article-title":"Correlation between high-risk HPV infection and p16\/Ki-67 abnormalities in Pap samples in a South Eastern Europe cohort","volume":"96","author":"Shalaby","year":"2024","journal-title":"J Med Virol."},{"issue":"9","key":"10.1016\/j.jgeb.2026.100701_b0085","first-page":"3100","article-title":"Differential expression of metallothionein and p21 in gastric cancer and some precursor lesions","volume":"26","author":"Helal","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100701_b0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13045-020-00943-w","article-title":"ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21","volume":"13","author":"Cosi","year":"2020","journal-title":"J Hematol Oncol."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100701_b0095","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","article-title":"Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jgeb.2026.100701_b0100","unstructured":"Amin MB, Edge S, Greene F, et al. (editors). AJCC Cancer Staging Manual (American Joint Committee on Cancer). 8th ed. Berlin, Germany: Springer International Publishing; (2017)."},{"issue":"6","key":"10.1016\/j.jgeb.2026.100701_b0105","first-page":"590","article-title":"Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer","volume":"73","author":"Janczewski","year":"2023","journal-title":"CA Cancer J Clin."},{"issue":"3","key":"10.1016\/j.jgeb.2026.100701_b0110","first-page":"233","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.jgeb.2026.100701_b0115","article-title":"Screening and prevention of colorectal cancer","volume":"374","author":"Kanth","year":"2021","journal-title":"BMJ."},{"issue":"9","key":"10.1016\/j.jgeb.2026.100701_b0120","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3390\/medicina59091646","article-title":"Colorectal cancer: from risk factors to oncogenesis","volume":"59","author":"Ionescu","year":"2023","journal-title":"Medicina (kaunas)."},{"issue":"10","key":"10.1016\/j.jgeb.2026.100701_b0125","first-page":"7893","article-title":"Addressing colon cancer patients' needs during follow-up consultations at the outpatient clinic: a multicenter qualitative observational study","volume":"30","author":"Vos","year":"2022","journal-title":"Support Care Cancer."},{"issue":"16_suppl","key":"10.1016\/j.jgeb.2026.100701_b0130","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1200\/JCO.2022.40.16_suppl.6560","article-title":"Disparity of treatment-related adverse events and outcome in patients with early-onset metastatic colorectal cancer (mCRC)","volume":"40","author":"Meng","year":"2022","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.jgeb.2026.100701_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109125","article-title":"Methionine enkephalin inhibits colorectal cancer by remodeling the immune status of the tumor microenvironment","volume":"111","author":"Wang","year":"2022","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.jgeb.2026.100701_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.801714","article-title":"Opioid receptor expression in colorectal cancer: a nested matched case-control study","volume":"12","author":"Belltall","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.jgeb.2026.100701_b0145","series-title":"Methionine enkephalin (MENK) inhibits human osteosarcomathrough opioid receptor (OGFR) and its related [D]","author":"Huang","year":"2023"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100701_b0150","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/2589977513666210127094222","article-title":"Low doses naltrexone: the potential benefit effects for its use in patients with cancer","volume":"13","author":"Couto","year":"2021","journal-title":"Curr Drug Res Rev."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100701_b0155","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1091\/mbc.e08-07-0681","article-title":"The OGF-OGFr axis utilizes the p16INK4a and p21WAF1\/CIP1 pathways to restrict normal cell proliferation","volume":"20","author":"Cheng","year":"2008","journal-title":"Mol Biol Cell."},{"key":"10.1016\/j.jgeb.2026.100701_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.801411","article-title":"Solid tumor opioid receptor expression and oncologic outcomes: analysis of the cancer genome atlas and genotype tissue expression project","volume":"12","author":"Belltall","year":"2022","journal-title":"Front Oncol."},{"issue":"2","key":"10.1016\/j.jgeb.2026.100701_b0165","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1200\/JCO.21.01752","article-title":"Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN cancer research group trial (E3311)","volume":"40","author":"Ferris","year":"2021","journal-title":"J Clin Oncol."},{"issue":"7942","key":"10.1016\/j.jgeb.2026.100701_b0170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41586-022-05551-x","article-title":"BRD8 maintains glioblastoma by epigenetic reprogramming of the p53 network","volume":"613","author":"Sun","year":"2023","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100701_b0175","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/s41467-020-15573-6","article-title":"p53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival","volume":"11","author":"Deng","year":"2020","journal-title":"Nat Commun."},{"key":"10.1016\/j.jgeb.2026.100701_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106068","article-title":"The effect of low-dose naltrexone on solid Ehrlich carcinoma in mice: the role of OGFr, BCL2, and immune response","volume":"78","author":"Aboalsoud","year":"2020","journal-title":"Int Immunopharmacol."}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:57:21Z","timestamp":1789559841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X26000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1687157X26000454"],"URL":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100701","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between expression of OGFR, P16, P21 and clinicopathological features of colorectal cancer patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of Academy of Scientific Research and Technology.","name":"copyright","label":"Copyright"}],"article-number":"100701"}}